Axonics: tour de table de 31 millions d’euros

Paolo Bossi

Dentons Paris et Palo Alto ont assisté Gilde Healthcare à l’occasion de son investissement dans Axonics Axonics, qui développe le premier système de Sacral Neuromodulation (r-SNM™)…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here